Drug · DIN 02450267
AFINITOR
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 9, 2018; first marketed April 5, 2016.
- Drug Identification Number (DIN)
- 02450267
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Everolimus L04AH02
- Class
- Human
- Record last updated
- June 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EVEROLIMUS | 7.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 24, 2015: NOC 17623Supplement to a New Drug Submission (SNDS) · New strength
Other DINs named AFINITOR
- DIN 02339501 · Marketed
- DIN 02339528 · Marketed
- DIN 02369257 · Marketed